Lars Bullinger
German Cancer Research Center(DE)Universität Ulm(DE)Max Delbrück Center(DE)Heidelberg University(DE)University Hospital Heidelberg(DE)Humboldt-Universität zu Berlin(DE)German Cancer Society(DE)Vivantes Klinikum(DE)National Center for Tumor Diseases(DE)Universitätsmedizin Göttingen(DE)German Marine Research Consortium(DE)Pharis Biotec (Germany)(DE)Berlin Institute of Health at Charité - Universitätsmedizin Berlin(DE)University Hospital Ulm(DE)Deutschen Konsortium für Translationale Krebsforschung(DE)Technische Universität Berlin(DE)Franklin University(US)Freie Universität Berlin(DE)Charité - Universitätsmedizin Berlin(DE)Charité - Universitätsmedizin Berlin(DE)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Cancer Genomics and Diagnostics, Protein Degradation and Inhibitors, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Genomic Classification and Prognosis in Acute Myeloid Leukemia(2016)4,279 cited
- → Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia(2000)3,286 cited
- → Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia(2008)1,607 cited
- → Use of Gene-Expression Profiling to Identify Prognostic Subclasses in Adult Acute Myeloid Leukemia(2004)995 cited
- → A 17-gene stemness score for rapid determination of risk in acute leukaemia(2016)896 cited
- → MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L(2011)888 cited